Route of administration other than oral for concomitant me­di­cation [Bioanalytics]

posted by qualityassurance – 2020-02-04 12:28 (1596 d 23:45 ago) – Posting: # 21141
Views: 3,570

Hello all,

We have given concomitant medication to subjects during clinical phase and the route of administration was topical, local (eye drops), IV, IM.

Can anyone suggest me :confused::confused: if it is required to include these medications in concomitant medication experiment if the route of administration is other than oral (e.g. IV, topical, eye drops) during clinical phase?

Complete thread:

UA Flag
Activity
 Admin contact
23,057 posts in 4,840 threads, 1,641 registered users;
133 visitors (1 registered, 132 guests [including 9 identified bots]).
Forum time: 13:13 CEST (Europe/Vienna)

Even though it’s applied science we’re
dealin’ with, it still is – science!    Leslie Z. Benet

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5